Ivermectin 12mg tablet contains an active component of Ivermectin. This medication has been used to treat several human parasitic infections, including onchocerciasis (river blindness), strongyloidiasis, lice, filariasis, and scabies. It has been instrumental in global efforts to control these diseases in regions where they are endemic. Onchocerciasis is a parasitic disease caused by the filarial worm Onchocerca volvulus, transmitted by black flies, leading to skin and eye symptoms. Strongyloidiasis is a parasitic infection caused by the roundworm Strongyloides stercoralis, often resulting in gastrointestinal and skin-related symptoms. Filariasis is a tropical and subtropical disease caused by filarial worms transmitted through mosquitoes, leading to lymphatic and subcutaneous tissue damage. Ivermectin 12mg tablet is often an affordable and cost-effective option for treating parasitic infections, making it accessible to many individuals, especially in resource-limited settings. Individuals with known hypersensitivity or allergy to this medication or any of its components should not use the medication. It is generally avoided during pregnancy, breastfeeding, and in children under a certain weight. It has been associated with central nervous system effects, and individuals with a history of seizure disorders or epilepsy may need careful consideration and monitoring when using the medication. It could have neuropsychiatric effects, posing a risk to individuals with certain mental health conditions. Individuals with severe chronic respiratory conditions, such as asthma or chronic obstructive pulmonary disease (COPD), may need careful consideration before using Ivermectin 12mg tablet, as it may cause respiratory symptoms. Additionally, interactions with other medications should be considered. Its use can cause ocular symptoms and potentially worsen eye conditions in some cases. The use of this medication in very young children, especially those weighing less than 15 kilograms, may be contraindicated. It's important to emphasize that the decision to use this medication or any medication in the older adult population should be made in consultation with a qualified healthcare provider.